Yana Chertock
Biographic Data
| ID | 7944909 |
|---|---|
| NAME | Yana Chertock |
| GIVEN NAMES | Yana |
| FAMILY NAME | Chertock |
| SIGNATURE | CHERTOCK Y |
| AFFILIATIONS | Fox Chase Cancer Center |
| ORCID | 0000-0002-3508-9143 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Development and user testing of gene pilot
Introduction Tumor genomic profiling (TGP) is used to optimize cancer treatment but is underutilized by Black patients, despite having disproportionately higher cancer morbidity and mortality. No interventions using electronic health decision support tools (eHealth DSTs) have been developed to assist patients with understanding this test or address barriers to uptake and communicating preferences with a doctor. Methods Using the Ottawa Decision S…
The Role of Medical Mistrust in Concerns about Tumor Genomic Profiling among Black and African American Cancer Patients
Tumor genomic profiling (TGP) is used in oncology practice to optimize cancer treatment and improve survival rates. However, TGP is underutilized among Black and African American (AA) patients, creating potential disparities in cancer treatment outcomes. Cost, accuracy, and privacy are barriers to genetic testing, but medical mistrust (MM) may also influence how Black and AA cancer patients perceive TGP. From December 2019 to February 2020, 112 B…
No prominent works on this page.
The Role of Medical Mistrust in Concerns about Tumor Genomic Profiling among Black and African American Cancer Patients
Tumor genomic profiling (TGP) is used in oncology practice to optimize cancer treatment and improve survival rates. However, TGP is underutilized among Black and African American (AA) patients, creating potential disparities in cancer treatment outcomes. Cost, accuracy, and privacy are barriers to genetic testing, but medical mistrust (MM) may also influence how Black and AA cancer patients perceive TGP. From December 2019 to February 2020, 112 B…
Development and user testing of gene pilot
Introduction Tumor genomic profiling (TGP) is used to optimize cancer treatment but is underutilized by Black patients, despite having disproportionately higher cancer morbidity and mortality. No interventions using electronic health decision support tools (eHealth DSTs) have been developed to assist patients with understanding this test or address barriers to uptake and communicating preferences with a doctor. Methods Using the Ottawa Decision S…
BRCA gene mutations in cancer (2 works) · Cancer Genomics and Diagnostics (2 works) · African american (1 work) · Bioinformatics (1 work) · Biology (1 work) · Cancer (1 work) · Computational biology (1 work) · Computer Science (1 work) · Ethics in Clinical Research (1 work) · Ethnology (1 work)